Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Clinical trial NCT00027586 · COMPLETED

Trial details

NCT number: NCT00027586
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Skin Neoplasms

Start date: 2001-09-01
Primary completion: 2005-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.